Hepatitis B, Chronic

• 

  Subject Areas on Research

  • A rationalized approach to the treatment of patients infected with hepatitis B. 
  • Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. 
  • Acute liver failure occurring immediately following anti-D immune globulin infusion in a patient with chronic hepatitis B infection. 
  • Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients. 
  • Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. 
  • Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. 
  • American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. 
  • Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. 
  • Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. 
  • Autoimmune hepatitis in a child with chronic hepatitis B virus infection. 
  • Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. 
  • Cost of chronic hepatitis B virus infection in Taiwan. 
  • Cross-Cultural Adaptation and Psychometric Assessment of the Liver Disease Symptom Index 2.0 to Measure Health-Related Quality of Life Among Iranian Patients With Chronic Hepatitis B. 
  • Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion. 
  • Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy. 
  • Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response? 
  • Evidence for reduced selection pressure on the hepatitis B virus core gene in hepatitis B e antigen-negative chronic hepatitis B. 
  • Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy. 
  • Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial. 
  • Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. 
  • Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). 
  • Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B. 
  • From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. 
  • Gene Editing: A New Tool for Viral Disease. 
  • HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study. 
  • HBV-specific T-cell responses in healthy seronegative sexual partners of patients with chronic HBV infection. 
  • HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. 
  • Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues. 
  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. 
  • Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy--pathogenesis and management. 
  • Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report. 
  • Hepatocellular Carcinoma Surveillance. 
  • Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. 
  • High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. 
  • IL28B: relevance extended to hepatitis B virus or limited to interferon-based therapies in hepatitis C virus? 
  • Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy. 
  • Is there an association between Health Related Quality of Life, socio-demographic status and Fatigue in Patients with Chronic Hepatitis B? 
  • Life threatening liver disease during treatment with monoclonal antibodies. 
  • Multidimensional Fatigue Inventory in People With Hepatitis B Infection: Cross-cultural Adaptation and Psychometric Evaluation of the Persian Version. 
  • Novel quantification of tenofovir disoproxil fumarate adherence in human immunodeficiency virus/hepatitis B coinfected patients with incomplete hepatitis B virus viral suppression. 
  • Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. 
  • Physicians' stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. 
  • Pradefovir, a liver-targeted prodrug of adefovir against HBV infection. 
  • Quantification of HBsAg and HBV-DNA during therapy with peginterferon alpha-2b plus lamivudine and peginterferon alpha-2b alone in a German chronic hepatitis B cohort. 
  • Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. 
  • Regulation of T cell function by microRNA-720. 
  • Regulation of T cell proliferation by JMJD6 and PDGF-BB during chronic hepatitis B infection. 
  • Relevance of hepatitis B core gene deletions in patients after kidney transplantation. 
  • Reply. 
  • Resistance management in chronic hepatitis B complicated by renal failure. 
  • Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. 
  • Screening for and treating hepatitis B virus in patients with HIV infection. 
  • Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated. 
  • Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients. 
  • Stemming the tide of hepatitis B virus related hepatocellular carcinoma? 
  • Targeting hepatitis B virus cccDNA using CRISPR/Cas9. 
  • Telbivudine versus lamivudine in patients with chronic hepatitis B. 
  • The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. 
  • Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. 
  • Viral quasi-species evolution during hepatitis Be antigen seroconversion. 
  • [A clinical study of viral dynamic change in patients with hepatitis B e antigen positive chronic hepatitis B by lamivudine treatment]. 
  • [A prospective study of histological changes after AraAMP treatment in patients with chronic hepatitis B infection]. 
  • [Diagnostics and therapy of chronic hepatitis B and C]. 
  • [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients]. 
  • [Liver transplantation in patients with HIV infection: a reality in 2004]. 
  • [Procedures for problematic situations with hepatitis B]. 
• 

  Keywords of People

  • Choi, Steven Sok, Associate Professor of Medicine, Medicine, Gastroenterology